Skip to main content

Site notifications

LIRAGLUTIDE SUN, LIRAGLUTIDE RBX, SOLLEEN Sun Pharma ANZ Pty Ltd

Product name
LIRAGLUTIDE SUN, LIRAGLUTIDE RBX, SOLLEEN
Accepted date
Jan-2024
Active ingredients
Liraglutide
Proposed indication
As an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients.
Application type
A (new medicine)
Publication date
Jan-2024

Help us improve the Therapeutic Goods Administration site